UK approves Moderna vaccine for 12-17 age group

Tuesday, 17 August 2021 16:49

By Reuters

Britain's health regulator has approved Moderna's COVID-19 vaccine for use in children aged 12 to 17 years.

The approval comes more than two months after Pfizer and German partner BioNTech's COVID-19 vaccine got regulatory nod for use in children aged 12 to 15.

Moderna's vaccine was recommended for use in adolescents by European regulators in July and is awaiting US authorisation.

It is currently approved for people over the age of 18 in the UK.

Britain's Joint Committee on Vaccination and Immunisation (JCVI) gave the go-ahead on August 4 for 16 and 17-year-olds to get their first dose of Pfizer's COVID-19 vaccine ahead of schools returning in September.

JCVI will make a decision on whether the vaccine will be deployed or not.

More from International News

23 arrested in India's Manipur after violent protests

Police arrested 23 people on Sunday in the north-eastern Indian state of Manipur for ransacking and setting fire to the homes of lawmakers and ministers, while hundreds demonstrated against recent violent killings in defiance of a curfew.
Russia pounds Ukraine's power grid in 'massive' air strike

Russia unleashed its largest wave of airstrikes on Ukraine in almost three months on Sunday, firing 120 missiles and 90 drones in a sweeping attack that killed at least seven people and caused "severe damage" to the power system, officials said.
Dozens killed, wounded in Israeli strike on residential building in Gaza's Beit Lahiya

Dozens of Palestinians were killed or injured in an Israeli strike on a multi-storey residential building in northern Gaza's Beit Lahiya on Sunday.
Bangladesh deaths from dengue cross 400 as outbreak worsens

Bangladesh is battling its worst outbreak of dengue in years, with more than 400 deaths, as rising temperatures and a longer monsoon season drive a surge in infections, leaving hospitals struggling to cope, particularly in urban areas.